Identification of predictors of response to NVP-AUY922, an HSP90 inhibitor, in an in vitro panel of human non-small-cell lung cancer (NSCLC) cell lines

被引：0
|
作者：
Garon, Edward B. [2 ]
Finn, Richard S. [2 ]
Dering, Judy [2 ]
Ginther, Charles [2 ]
Adhami, Shariar [2 ]
Pitts, Sharon [2 ]
Kamranpour, Naeimeh [2 ]
Hosmer, Wylie [2 ]
Jensen, Rugaard Michael [1 ]
Quadt, Cornelia [1 ]
Slamon, Dennnis J. [2 ]
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S599 / S599
页数：1
相关论文
共 50 条
  • [21] Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
    Bao, Xiao-Hong
    Takaoka, Munenori
    Hao, Hui-Fang
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Sakurama, Kazufumi
    Takigawa, Nagio
    Nakajima, Motowo
    Fujiwara, Toshiyoshi
    Naomoto, Yoshio
    ONCOLOGY REPORTS, 2013, 29 (01) : 45 - 50
  • [22] The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer
    Park, Kang-Seo
    Yang, Hannah
    Choi, Junyoung
    Seo, Seyoung
    Kim, Deokhoon
    Lee, Chang Hoon
    Jeon, Hanwool
    Kim, Sang-We
    Lee, Dae Ho
    CANCER LETTERS, 2017, 406 : 47 - 53
  • [23] NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Michael Rugaard Jensen
    Joseph Schoepfer
    Thomas Radimerski
    Andrew Massey
    Chantale T Guy
    Josef Brueggen
    Cornelia Quadt
    Alan Buckler
    Robert Cozens
    Martin J Drysdale
    Carlos Garcia-Echeverria
    Patrick Chène
    Breast Cancer Research, 10
  • [24] HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells
    Liu, Jinhao
    Sun, Wei
    Dong, Wenwu
    Wang, Zhihong
    Qin, Yuan
    Zhang, Ting
    Zhang, Hao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (02) : 313 - 319
  • [25] Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
    Kuehnel, Annett
    Schilling, Daniela
    Combs, Stephanie E.
    Haller, Bernhard
    Schwab, Melissa
    Multhoff, Gabriele
    CELLS, 2019, 8 (10)
  • [26] Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitize tumor cell lines under acute hypoxia
    Blassl, C.
    Djuzenova, C. S.
    Katzer, A.
    Tripp, C.
    Roloff, K.
    Bernhard, M.
    Flentje, M.
    Jensen, M. R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 74 - 74
  • [27] HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice
    Chittoor-Vinod, Vinita G.
    Bazick, Hannah
    Todd, Adrian G.
    Falk, Darin
    Morelli, Kathryn H.
    Burgess, Robert W.
    Foster, Thomas C.
    Notterpek, Lucia
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (06): : 2890 - 2902
  • [28] Pharmakokinetic/phamacodynamic relationship in human xenograft models and PBMC's treated with the Hsp90 inhibitor NVP-AUY922
    Jensen, M. R.
    Ide, S.
    Brueggen, J.
    Schoepfer, J.
    Motwani, M.
    Wang, X.
    Radimerski, T.
    Quadt, C.
    Garcia-Echeverria, C.
    Chene, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 50 - 50
  • [29] Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
    Hartmann, Susanne
    Gunther, Nadine
    Biehl, Marlene
    Katzer, Astrid
    Kuger, Sebastian
    Worschech, Eike
    Sukhorukov, Vladimir L.
    Krohne, Georg
    Zimmermann, Heiko
    Flentje, Michael
    Djuzenova, Cholpon S.
    CANCER LETTERS, 2013, 331 (02) : 200 - 210
  • [30] 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
    Nagengast, Wouter B.
    de Korte, Maarten A.
    Munnink, Thijs H. Oude
    Timmer-Bosscha, Hetty
    den Dunnen, Wifred F.
    Hollema, Harry
    de Jong, Johan R.
    Jensen, Michael R.
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    van Dongen, Guus A. M. S.
    Lub-de Hooge, Marjolijn N.
    Schroder, Carolien P.
    de Vries, Elisabeth G. E.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (05) : 761 - 767
12345